AU6224790A - Proteins having anticoagulant properties - Google Patents

Proteins having anticoagulant properties

Info

Publication number
AU6224790A
AU6224790A AU62247/90A AU6224790A AU6224790A AU 6224790 A AU6224790 A AU 6224790A AU 62247/90 A AU62247/90 A AU 62247/90A AU 6224790 A AU6224790 A AU 6224790A AU 6224790 A AU6224790 A AU 6224790A
Authority
AU
Australia
Prior art keywords
proteins
inhibitors
factor
anticoagulant properties
inhibit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU62247/90A
Other versions
AU639257B2 (en
Inventor
Victor M. Garsky
Michael P. Neeper
George P. Vlasuk
Lloyd H. Waxman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU6224790A publication Critical patent/AU6224790A/en
Application granted granted Critical
Publication of AU639257B2 publication Critical patent/AU639257B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Proteins which specifically inhibit coagulation Factor Xa. The inhibitors, which do not inhibit Factor VIIa, kallikrein, trypsin, chymotrypsin, thrombin, urokinase, tissue plasminogen activator, plasmin, elastase, Factor XIa or S. aureus V8 protease, are polypeptides of 60 amino acid residues. The inhibitors may be purified from Ornithodoros moubata extract, synthesized, or produced using a recombinant DNA yeast expression system.
AU62247/90A 1989-09-07 1990-09-06 Proteins having anticoagulant properties Ceased AU639257B2 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US40403389A 1989-09-07 1989-09-07
US404033 1989-09-07
US49830790A 1990-03-23 1990-03-23
US498307 1990-03-23
US56516490A 1990-08-13 1990-08-13
US565164 1990-08-13

Publications (2)

Publication Number Publication Date
AU6224790A true AU6224790A (en) 1991-03-14
AU639257B2 AU639257B2 (en) 1993-07-22

Family

ID=27410566

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62247/90A Ceased AU639257B2 (en) 1989-09-07 1990-09-06 Proteins having anticoagulant properties

Country Status (8)

Country Link
EP (1) EP0419099B1 (en)
JP (1) JP3034926B2 (en)
AT (1) ATE133962T1 (en)
AU (1) AU639257B2 (en)
CA (1) CA2024697A1 (en)
DE (1) DE69025247T2 (en)
DK (1) DK0419099T3 (en)
IE (1) IE70759B1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU618364B2 (en) * 1988-06-04 1991-12-19 Hoechst Aktiengesellschaft Amblyommin, a new active substance for anticoagulant therapy
AU677930B2 (en) * 1990-09-04 1997-05-08 Millennium Pharmaceuticals, Inc. Recombinant agents affecting haemophilia

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4136087A1 (en) * 1991-10-31 1993-05-06 Basf Ag, 6700 Ludwigshafen, De NEW THROMBININHIBITOR PROTEIN FROM TICKS
US5321010A (en) * 1991-12-10 1994-06-14 Merck & Co., Inc. Proteins for inhibiting adhesion of platelets to collagen
AU5670494A (en) * 1992-12-01 1994-06-22 Merck & Co., Inc. Anticoagulant proteins
WO1995011691A1 (en) * 1993-10-29 1995-05-04 Merck & Co., Inc. Antithrombotic proteins
US5872098A (en) * 1995-06-05 1999-02-16 Corvas International, Inc. Nematode-extracted anticoagulant protein
CA2202351A1 (en) * 1994-10-18 1996-04-25 George Phillip Vlasuk Nematode-extracted serine protease inhibitors and anticoagulant proteins
EP1772516A1 (en) 1994-10-18 2007-04-11 Dendreon Corporation Pharmaceutical compositions for the treatment of thrombosis
US5866542A (en) * 1994-10-18 1999-02-02 Corvas International, Inc. Nematode-extracted anticoagulant protein
US5945275A (en) * 1994-10-18 1999-08-31 Corvas International, Inc. Nematode-extracted anticoagulant protein
US5863894A (en) * 1995-06-05 1999-01-26 Corvas International, Inc. Nematode-extracted anticoagulant protein
US5866543A (en) * 1995-06-05 1999-02-02 Corvas International, Inc. Nematode-extracted anticoagulant protein
US6245741B1 (en) 1998-05-19 2001-06-12 Washington University Protein Z-dependent protease inhibitor
US7479502B2 (en) 2002-12-03 2009-01-20 Pharmacyclics, Inc. 2-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors
JP2009510105A (en) 2005-09-28 2009-03-12 バイオバスキュラー インコーポレーティッド Methods and compositions for inhibiting platelet and cell adhesion, cell migration, and inflammation
CN112521466B (en) * 2020-01-22 2022-06-17 天津科技大学 Signal peptide mutant for improving secretion of heterologous protein and application thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU618364B2 (en) * 1988-06-04 1991-12-19 Hoechst Aktiengesellschaft Amblyommin, a new active substance for anticoagulant therapy
AU677930B2 (en) * 1990-09-04 1997-05-08 Millennium Pharmaceuticals, Inc. Recombinant agents affecting haemophilia

Also Published As

Publication number Publication date
CA2024697A1 (en) 1991-03-08
DE69025247T2 (en) 1996-09-12
ATE133962T1 (en) 1996-02-15
IE70759B1 (en) 1996-12-30
JPH03178997A (en) 1991-08-02
JP3034926B2 (en) 2000-04-17
EP0419099A1 (en) 1991-03-27
DE69025247D1 (en) 1996-03-21
EP0419099B1 (en) 1996-02-07
IE903245A1 (en) 1991-03-13
DK0419099T3 (en) 1996-03-11
AU639257B2 (en) 1993-07-22

Similar Documents

Publication Publication Date Title
AU639257B2 (en) Proteins having anticoagulant properties
Vlasuk Structural and functional characterization of tick anticoagulant peptide (TAP): a potent and selective inhibitor of blood coagulation factor Xa
AU623769B2 (en) Proteinase inhibitors, process for the preparation thereof and medicaments containing these
Petersen et al. Effect of leukocyte proteinases on tissue factor pathway inhibitor
CA2058935A1 (en) Pharmaceutical compositions and method for treatment using alzheimer's amyloid peptides
WO1996035788A3 (en) Kunitz type protease inhibitors
IE881666L (en) Peptide boronic acid inhibitors of trypsin-like proteases
EP1484339A3 (en) Kallikrein-inhibiting "Kunitz Domain" proteins and nucleic acids encoding the same
DK0952215T3 (en) Protease for activating coagulation factor VII
WO2001004146A3 (en) Ecarin polypeptides, polynucleotides encoding ecarin, and methods for use thereof
Watorek et al. Neutrophil elastase and cathepsin G: structure, function, and biological control
FI924306A0 (en) FOERBAETTRAT VAEVNADSLIM SOM FRAMSTAELLTS GENOM ANVAENDNING AV KRYOFAELLNING.
NZ319474A (en) Guanidino protease inhibitors
Erdjument et al. Antithrombin Milano, single amino acid substitution at the reactive site, Arg393 to Cys
EP1509541A4 (en) Novel recombinant anticoagulant proteins
Aulak et al. Chymotrypsin inhibitory activity of normal C1‐inhibitor and a P1 Arg to His mutant: Evidence for the presence of overlapping reactive centers
Schoenberger et al. Limited proteolysis of Cl‐inhibitor by chymotrypsin‐like proteinases
EP0218479A3 (en) Reagent and process
Knäuper et al. Inactivation of human plasma C1‐inhibitor by human PMN leucocyte matrix metalloproteinases
IE890270L (en) Proteins derived from human alpha 2 plasmin inhibitor
NZ256246A (en) Serine leukocyte protease inhibitor, recombinant preparation thereof, and treatment of a retroviral infection
Curtis et al. Interaction of a trypsin-like enzyme of Porphyromonas gingivalis W83 with antithrombin III
Callas et al. Fibrinolytic compromise by synthetic and recombinant thrombin inhibitors: implications in the treatment of thrombotic disorders
JPH0767640A (en) New trypsin-like enzyme
RU2218353C2 (en) Human bicunin (variants), dna encoding its and expression vector (variants)